跳至正文
研究论文

MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.

Cao Xinguang, Zhao Ruihua, Chen Qiong, Zhao Yuzhou, Zhang Bin, Zhang Yanzhen, Yu Juan, Han Guangsen, Cao Wei, Li Jiansheng, Chen Xiaobing · 共同作者

Cancer biomarkers : section A of Disease markers2015; 15(6): 717--23

DOI
10.3233/cbm-150513
PMID
26406400

摘要

关键词 · Esophageal squamous cell carcinoma, MALAT1, long non-coding RNA

Background

Recent studies have demonstrated that MALAT1 is involved in cancer metastasis and recurrence and it is up-regulated in cervical cancer, hepatocellular carcinoma, non-small cell lung cancer (NSCLC) and colorectal cancer. However, the role of MALAT1 in esophageal squamous cell carcinoma (ESCC) is still unclear.

Methods

The expression of MALAT1 was evaluated in cancer tissue and paired adjacent normal tissue samples from 77 middle thoracic ESCC patients who received radical surgical resection using QRT-PCR. The correlations between the expression levels of MALAT1 and clinical-pathological features and Patients' survival were also analysed.

Results

MALAT1 expression was increased in ESCC tissue than in adjacent normal tissue samples (P< 0.001). MALAT1 level was positively related to pT stage (P= 0.01). Kaplan-Meier analysis showed high expression levels of MALAT1 ware correlated with poor prognosis in ESCC patients. Patients with a high level of MALAT1 had a shorter DFS and OS than those with low MALAT1 expression (P= 0.04 and 0.038, respectively). On Multivariate analysis, The HR of MALAT1 expression was 1.76 (95% CI = 0.97-3.21, P= 0.06) for DFS and 1.81 (95% CI = 0.97-3.41, P$=0.06) for OS.

Conclusions

Our results showed that MALAT1 expression may serve as a predictive marker for middle thoracic ESCC patients who have been received radical resection.

陈琼发布于 219 字约 2 分钟阅读浏览量加载中…

留言板

欢迎留下与本页内容相关的问题、建议或想法。

正在读取留言…

审核通过后,昵称和留言将公开显示。请勿填写私人联系方式。

← 返回论文列表